Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Giuseppe Bronte, Enrico Bronte, Giuseppina Novo, Gianfranco Pernice, Francesca Lo Vullo, Emmanuela Musso, Fabrizio Bronte, Eliana Gulotta, Sergio Rizzo, Christian Rolfo, Nicola Silvestris, Viviana Bazan, Salvatore Novo & Antonio Russo. (2015) Conquests and perspectives of cardio-oncology in the field of tumor angiogenesis-targeting tyrosine kinase inhibitor-based therapy. Expert Opinion on Drug Safety 14:2, pages 253-267.
Read now
Read now
Giuseppe Bronte, Giovanni Sortino, Francesco Passiglia, Sergio Rizzo, Francesca Lo Vullo, Antonio Galvano, Viviana Bazan, Christian Rolfo & Antonio Russo. (2015) Monoclonal antibodies for the treatment of non-haematological tumours: update of an expanding scenario. Expert Opinion on Biological Therapy 15:1, pages 45-59.
Read now
Read now
Articles from other publishers (12)
Silvia Inés Guerrero Macías, Juan Javier Acevedo, Helena Facundo Navia & Oscar Alexander Guevara Cruz. (2023) Mutación del gen KRAS en pacientes llevados a resecciones hepáticas por cáncer colorrectal. ¿Hay ventaja en las resecciones anatómicas?. Revista colombiana de Gastroenterología 38:1, pages 19-27.
Crossref
Crossref
Jian-Hong Peng, Yi Tai, Yi-Xin Zhao, Bao-Jia Luo, Qing-Jian Ou, Zhi-Zhong Pan, Lin Zhang & Zhen-Hai Lu. (2021) Programmed death-ligand 1 expression in the tumour stroma of colorectal liver oligometastases and its association with prognosis after liver resection. Gastroenterology Report 9:5, pages 443-450.
Crossref
Crossref
Junfeng Huang, Qing Zang, Yaokai Wen, Zhe Pan, Zhiyuan Yao, Mingkai Huang, Jiongqiang Huang, Jingsong Chen & Rongchang Wang. (2021) Prognostic value of KRAS mutation in patients undergoing pulmonary metastasectomy for colorectal cancer: A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology 160, pages 103308.
Crossref
Crossref
Amin El-Heliebi & Ellen Heitzer. 2019. Nucleic Acid Nanotheranostics. Nucleic Acid Nanotheranostics
133
188
.
William Torén, Daniel Ansari & Roland Andersson. (2018) Immunohistochemical investigation of prognostic biomarkers in resected colorectal liver metastases: a systematic review and meta-analysis. Cancer Cell International 18:1.
Crossref
Crossref
William Torén, Daniel Ansari, Bodil Andersson, Lidewij Spelt & Roland Andersson. (2018) Thymidylate synthase: a predictive biomarker in resected colorectal liver metastases receiving 5-FU treatment. Future Oncology 14:4, pages 343-351.
Crossref
Crossref
S. M. Chiavenna, J. P. Jaworski & A. Vendrell. (2017) State of the art in anti-cancer mAbs. Journal of Biomedical Science 24:1.
Crossref
Crossref
Samantha Perakis, Martina Auer, Jelena Belic & Ellen Heitzer. 2017.
73
153
.
Francesco Passiglia, Giuseppe Bronte, Viviana Bazan, Antonio Galvano, Bruno Vincenzi & Antonio Russo. (2016) Can KRAS and BRAF mutations limit the benefit of liver resection in metastatic colorectal cancer patients? A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology 99, pages 150-157.
Crossref
Crossref
Daniele Fanale, Marta Castiglia, Viviana Bazan & Antonio Russo. 2016. Non-coding RNAs in Colorectal Cancer. Non-coding RNAs in Colorectal Cancer
207
228
.
Enrico Bronte, Giuseppe Bronte, Giuseppina Novo, Fabrizio Bronte, Maria Grazia Bavetta, Giuseppe Lo Re, Giuseppe Brancatelli, Viviana Bazan, Clara Natoli, Salvatore Novo & Antonio Russo. (2015) What links BRAF to the heart function? new insights from the cardiotoxicity of BRAF inhibitors in cancer treatment. Oncotarget 6:34, pages 35589-35601.
Crossref
Crossref
Giuseppe Bronte, Nicola Silvestris, Marta Castiglia, Antonio Galvano, Francesco Passiglia, Giovanni Sortino, Giuseppe Cicero, Christian Rolfo, Marc Peeters, Viviana Bazan, Daniele Fanale, Antonio Giordano & Antonio Russo. (2015) New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: do all roads lead to RAS?. Oncotarget 6:28, pages 24780-24796.
Crossref
Crossref